These two features of SLC7A11, its non-essential nature in normal physiology and its high expression in cancer, suggest that targeting SLC7A11 may selectively kill tumor cells and impair tumor growth while preserving normal cells or tissues. The gene discussed is SLC7A11; the disease is neoplasm.